These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31402613)
41. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry. Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496 [TBL] [Abstract][Full Text] [Related]
42. Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. Wilson D; Charidimou A; Shakeshaft C; Ambler G; White M; Cohen H; Yousry T; Al-Shahi Salman R; Lip GY; Brown MM; Jäger HR; Werring DJ; Neurology; 2016 Jan; 86(4):360-6. PubMed ID: 26718576 [TBL] [Abstract][Full Text] [Related]
43. Risk of intracranial hemorrhage in patients using anticoagulant therapy for atrial fibrillation after cerebral microbleeds combined with acute ischemic stroke: a meta-analysis. Zhao B; Yuan Y; Li Z; Chen Y; Gao Y; Yang B; Wu J; Jia W Front Neurol; 2024; 15():1372231. PubMed ID: 38560733 [TBL] [Abstract][Full Text] [Related]
44. Bleeding complications with oral anticoagulants in the elderly: an observational study. Peeterbroeck J; Danguy C; Lelubre C; Meulemans M; Higuet S Geriatr Psychol Neuropsychiatr Vieil; 2016 Dec; 14(4):406-412. PubMed ID: 27507064 [TBL] [Abstract][Full Text] [Related]
48. Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin. Melmed KR; Lyden P; Gellada N; Moheet A J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1874-1882. PubMed ID: 28647419 [TBL] [Abstract][Full Text] [Related]
49. Use of anticoagulant therapy and cerebral microbleeds: a systematic review and meta-analysis. Cheng Y; Wang Y; Song Q; Qiu K; Liu M J Neurol; 2021 May; 268(5):1666-1679. PubMed ID: 31616992 [TBL] [Abstract][Full Text] [Related]
50. Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. Staerk L; Fosbøl EL; Lamberts M; Bonde AN; Gadsbøll K; Sindet-Pedersen C; Holm EA; Gerds TA; Ozenne B; Lip GYH; Torp-Pedersen C; Gislason GH; Olesen JB Eur Heart J; 2018 May; 39(19):1698-1705a. PubMed ID: 29165556 [TBL] [Abstract][Full Text] [Related]
52. [Oral anticoagulation in atrial fibrillation: differential therapy with non vitamin K antagonist oral anticoagulants (NOAC) and vitamin K antagonists (VKA)]. Sucker C; Litmathe J; Berthold HK MMW Fortschr Med; 2019 Oct; 161(Suppl 6):15-23. PubMed ID: 31587168 [TBL] [Abstract][Full Text] [Related]
53. Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study. Denas G; Gennaro N; Ferroni E; Fedeli U; Saugo M; Zoppellaro G; Padayattil Jose S; Costa G; Corti MC; Andretta M; Pengo V Int J Cardiol; 2017 Dec; 249():198-203. PubMed ID: 28935464 [TBL] [Abstract][Full Text] [Related]
54. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group. Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595 [TBL] [Abstract][Full Text] [Related]
55. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy. De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115 [TBL] [Abstract][Full Text] [Related]
56. The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage. Dibu JR; Weimer JM; Ahrens C; Manno E; Frontera JA Neurocrit Care; 2016 Jun; 24(3):413-9. PubMed ID: 26545367 [TBL] [Abstract][Full Text] [Related]
57. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysis. Wilson D; Charidimou A; Ambler G; Fox ZV; Gregoire S; Rayson P; Imaizumi T; Fluri F; Naka H; Horstmann S; Veltkamp R; Rothwell PM; Kwa VI; Thijs V; Lee YS; Kim YD; Huang Y; Wong KS; Jäger HR; Werring DJ Neurology; 2016 Oct; 87(14):1501-1510. PubMed ID: 27590288 [TBL] [Abstract][Full Text] [Related]
58. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304 [TBL] [Abstract][Full Text] [Related]
59. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants. Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605 [TBL] [Abstract][Full Text] [Related]
60. Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists. Auer E; Frey S; Kaesmacher J; Hakim A; Seiffge DJ; Goeldlin M; Arnold M; Fischer U; Jung S; Meinel TR J Neurol; 2019 Sep; 266(9):2263-2272. PubMed ID: 31165232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]